Across
- 2. flail chest is manifested by this type of respiratory movement
- 4. this medication, used for tuberculosis treatment, causes body secretions to turn orange in color
- 6. a client with histoplasmosis requires this type of medication treatment
- 7. when administering inhaled respiratory medications, this drug class always comes before the steroid
- 9. this lower respiratory disease is manifested by paroxysms of coughing, requires droplet precautions, and may be prevented with the Tdap vaccine
- 10. immediate treatment for a client with pulmonary embolism, without respiratory distress
- 11. adventitious breath sounds typically associated with airway narrowing and/or obstruction
- 13. the priority treatment for a client with pneumo or hemothorax
- 15. a tension pneumothorax is manifested by this urgent assessment finding
- 16. Pneumocystis jirovecii is an opportunistic pneumonia found within this population
- 18. right-sided heart failure that may manifest as exertional dyspnea, JVD, anasarca, & weight gain
- 20. the diagnostic test for cystic fibrosis, measures the amount of sodium and chloride excreted in the client's sweat
- 22. Complication with fracture of 3 or more consecutive ribs or of 2 breaks in more than one rib
- 23. exposure to this chemical may lead to the development of mesotheliomas
- 24. abrupt, sharp onset of pain, worse with inspiration, presents with shallow/rapid respirations and possibly pleural friction rub
- 25. the affect of cystic fibrosis on the reproductive tract often leads to:
Down
- 1. increased sputum volume, increased sputum purulence, and increased dyspnea are manifestations of this COPD complication
- 3. a client who has been working in the demolition of 100 year old barn may present with:
- 5. collapsed, airless alveoli, often manifests as diminished/absent breath sounds
- 8. medical emergency caused by excess fluid in the lungs, may manifest as pink, frothy sputum
- 12. the type of genetic mutation that leads to development of cystic fibrosis
- 14. classic finding in clients with COPD related to increased AP diameter
- 17. the greatest risk factor contributing to lung disease
- 19. this mediction, used for tuberculosis treatment, may not be administered with alcohol as it is likely to cause hepatotoxicity
- 21. structural abnormality seen in clients with COPD, typically a result of alveolar destruction without fibrosis
